Patents Assigned to Proteus S.A.
  • Patent number: 9249150
    Abstract: Phycotoxins are purified from a mixture of phycotoxins produced in a continuous process. Cyanobacteria are produced in a continuous culture, then lyzed, the cells pelleted and extracted, and the extract purified using an organic solvent-aqueous mixture and repeated passage through a diatomaceous earth column. The column is washed with acetic acid, then the neosaxitoxin extracted with an alcohol-water mixture. The eluate is passed through activated charcoal columns, which are washed with distilled water to remove the retained pigments and impurities, the further purified by HPLC. In one embodiment, the process produces only neosaxitoxin and saxitoxin. In another embodiment, the process produces only GTX2/3.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: February 2, 2016
    Assignee: PROTEUS S.A.
    Inventor: Marcelo Santiago Lagos Gonzalez
  • Patent number: 8957207
    Abstract: Methods for producing phycotoxins from natural sources, wherein the phycotoxins have a definite compositional profile are described herein. In one embodiment, the phycotoxins are produced by cyanobacteria. In one embodiment, the phycotoxins are produced by continuously culturing cyanobacteria under strictly controlled conditions in order to produce a definite compositional profile. In another embodiment, organic nutrients are added to the culture that allows for higher concentrations of neosaxitoxin and saxitoxin or gonyaulatoxins 2 and 3 per weight of the algae. The phycotoxins are isolated primarily from the bacteria but can also be isolated from the culture medium. In one embodiment, the cyanobacteria produce only neosaxitoxin and saxitoxin in a ratio of about 6:1, 5:1, 4:1, or 3:1. In a preferred embodiment, the amount of saxitoxin is less than 20% by weight of the total amount of neosaxitoxin and saxitoxin produced. In another embodiment, the cyanobacteria produce only GTX2 and GTX 3.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: February 17, 2015
    Assignee: Proteus S.A.
    Inventor: Marcelo Santiago Lagos González
  • Patent number: 8952152
    Abstract: Phycotoxins are purified from a mixture of phycotoxins produced in a continuous process. Cyanobacteria are produced in a continuous culture, then lyzed, the cells pelleted and extracted, and the extract purified using an organic solvent-aqueous mixture and repeated passage through a diatomaceous earth column. The column is washed with acetic acid, then the neosaxitoxin extracted with an alcohol-water mixture. The eluate is passed through activated charcoal columns, which are washed with distilled water to remove the retained pigments and impurities, the further purified by HPLC. In one embodiment, the process produces only neosaxitoxin and saxitoxin. In another embodiment, the process produces only GTX2/3.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: February 10, 2015
    Assignee: Proteus S.A.
    Inventor: Marcelo Santiago Lagos González
  • Publication number: 20120065217
    Abstract: Phycotoxins are purified from a mixture of phycotoxins produced in a continuous process. Cyanobacteria are produced in a continuous culture, then lyzed, the cells pelleted and extracted, and the extract purified using an organic solvent-aqueous mixture and repeated passage through a diatomaceous earth column. The column is washed with acetic acid, then the neosaxitoxin extracted with an alcohol-water mixture. The eluate is passed through activated charcoal columns, which are washed with distilled water to remove the retained pigments and impurities, the further purified by HPLC. In one embodiment, the process produces only neosaxitoxin and saxitoxin. In another embodiment, the process produces only GTX2/3.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 15, 2012
    Applicant: PROTEUS S.A.
    Inventor: Marcelo Santiago Lagos González
  • Patent number: 8017318
    Abstract: The invention concerns a method for detecting a known function, from nucleic acids present in a sample, characterized in that it comprises the following steps: (a) preparing, from the nucleic acids of the sample, nucleic acid molecules comprising the gene(s) coding for the protein(s) corresponding to said function, and the control elements required for the transcription and the translation of said gene(s); (b) in vitro transcription and translation of the nucleic acid molecule prepared in step (a); (c) detecting and/or measuring the function corresponding to the protein(s) produced in step (b).
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: September 13, 2011
    Assignee: Proteus S.A.
    Inventors: Jean François Bloch, Sandrine Dautel, Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Patent number: 7983849
    Abstract: The invention relates to methods of determining the mutational load of a gene bank obtained by random mutagenesis of a gene of interest by preparing a chart linking the mutational load of a gene bank obtained by random mutagenesis of a model gene with the fraction of mutated model genes observed in the bank; performing, in parallel, random mutagenesis of the model gene used for preparing the chart and the gene of interest to obtain the corresponding mutated gene banks; determining the mutational load of the gene bank obtained using the model gene on the basis of the chart plotted; and applying a correction factor to the mutational load of the mutated model gene bank to determine the mutational load in the gene bank of the mutated genes of interest.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: July 19, 2011
    Assignee: Proteus S.A.
    Inventors: Matthieu Chodorge, Laurent Fourage, Fabrice Lefevre, Jean-Michel Masson
  • Patent number: 7595181
    Abstract: The present invention relates to a newly identified hydrolase from thermophilic microorganisms having thermostable properties, and more specifically, to a novel thermostable hydrolase showing high activity at high temperatures.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: September 29, 2009
    Assignee: Proteus S.A.
    Inventors: Burghard Grüning, Geoffrey Hills, Thomas Veit, Christian Weitemeyer, Olivier Favre-Bulle, Fabrice Lefevre, Hong-Khanh Nguyen, Gilles Ravot
  • Publication number: 20080139397
    Abstract: The present invention relates to a method used to determine the mutational load of a gene bank obtained by means of random mutagenesis of a gene of interest comprising: a) the preparation of a chart linking the mutational load (ML) of gene bank obtained by means of random mutagenesis of a model gene with the fraction of mutated model genes observed in said bank; b) the random mutagenesis of the model gene used for the preparation of the chart for step (a) and the gene of interest to obtain the corresponding mutated gene banks; c) the determination of the mutational load (ML) of the gene bank obtained using the model gene in step (b) on the basis of the chart plotted in step (a); d) the application of a correction factor (CF) to the mutational load (ML) of the mutated model gene bank determined in step (c) to determine the mutational load (ML) of the banks of mutated genes of interest from step (b).
    Type: Application
    Filed: June 7, 2005
    Publication date: June 12, 2008
    Applicant: Proteus S.A.
    Inventors: Matthieu Chodorge, Laurent Fourage, Fabrice Lefivre, Jean-Michel Masson
  • Patent number: 7303897
    Abstract: The invention relates to a fragmentation process that depends on mismatches between two strands of parental polynucleotides. One embodiment, comprises a method for preparing polynucleotide fragments of DNA comprising formation of heteroduplex molecules by hybridizing polynucleotides. The invention also provides a method and process of forming fragments which can be used with any shuffling process or combination of shuffling processes.
    Type: Grant
    Filed: November 17, 2003
    Date of Patent: December 4, 2007
    Assignee: Proteus S.A.
    Inventors: Daniel Dupret, Fabrice Lefevre, Laurent Fourage
  • Publication number: 20070264680
    Abstract: The present invention provides methods and test-kits for rapidly detecting and/or quantifying a group of organism, cultivable or not cultivable, sharing the same enzymatic activity. In particular, the methods and kits can be used for example in the field of cosmetics, where the activities of (microbial) enzymes, which are responsible for malodor or dandruff, are detected as an indicator for the presence of particular groups of microorganisms. Furthermore, the effect on substances acting on the causative microbes can be determined rapidly, easily and at low cost.
    Type: Application
    Filed: March 21, 2005
    Publication date: November 15, 2007
    Applicant: PROTEUS S.A.
    Inventors: Petra Allef, Burghard Gruning, Gilles Ravot, Denis Wahler
  • Patent number: 6991922
    Abstract: The object of this invention is a process for the creation of at least one recombinant polynucleotide sequence comprising a step of oriented ligation of fragments derived from a bank of at least two polynucleotide sequences, and optionally cloning the recombinant polynucleotide sequences, and the selection of polynucleotide sequences offering advantageous characteristics compared to one or several reference sequences.
    Type: Grant
    Filed: April 25, 2001
    Date of Patent: January 31, 2006
    Assignee: Proteus S.A.
    Inventors: Daniel Dupret, Fabrice Lefevre, Jean-Michel Masson
  • Publication number: 20050221378
    Abstract: Ligation-mediated method of recombining polynucleotides in vitro. Polynucleotides from a library are fragmented and the fragments are hybridized to an assembly template. The hybridized fragments are iteratively re-hybridized and ligated until the ends of the hybridized fragments are adjacent to the ends of other hybridized fragments on the assembly template. A final ligation produces recombined polynucleotides.
    Type: Application
    Filed: June 3, 2005
    Publication date: October 6, 2005
    Applicant: Proteus S.A.
    Inventors: Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Patent number: 6951719
    Abstract: Ligation-mediated method of recombining polynucleotides in vitro. Polynucleotides from a library are fragmented and the fragments are hybridized to an assembly template. The hybridized fragments are iteratively re-hybridized and ligated until the ends of the hybridized fragments are adjacent to the ends of other hybridized fragments on the assembly template. A final ligation produces recombined polynucleotides.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: October 4, 2005
    Assignee: Proteus S.A.
    Inventors: Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Patent number: 6911307
    Abstract: The present invention relates to a method of detection in vitro of a target substance in a sample. The sample can comprise, among other things, a nucleic sequence or more generally any type of substance. In particular, the present invention provides a method of detection comprising (i) specificly labeling a substance with a reporter gene and any sequences necessary for the in vitro expression of the reporter gene; (ii) in vitro transcription and translation of the reporter gene; and (iii) in vitro detection of a reporter protein coded by the reporter gene.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: June 28, 2005
    Assignee: Proteus S.A.
    Inventors: Sandrine Dautel, Cécile Persillon, Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Patent number: 6818396
    Abstract: The invention concerns a method for determining the activity of a substance using a functional test, characterized in that it consists in detecting and/or measuring the variation of a known function corresponding to one or several proteins produced in vitro in the presence and in the absence of said substances or to the substance in the presence or in the absence of one or several proteins produces in vitro.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: November 16, 2004
    Assignee: Proteus S.A.
    Inventors: Jean François Bloch, Daniel Dupret, Fabrice Lefevre, Sandrine Dautel, Jean-Michel Masson
  • Publication number: 20040214197
    Abstract: The invention relates to a fragmentation process that depends on mismatches between two strands of parental polynucleotides. One embodiment, comprises a method for preparing polynucleotide fragments of DNA comprising formation of heteroduplex molecules by hybridizing polynucleotides. The invention also provides a method and process of forming fragments which can be used with any shuffling process or combination of shuffling processes.
    Type: Application
    Filed: November 17, 2003
    Publication date: October 28, 2004
    Applicant: PROTEUS S.A.
    Inventors: Daniel Dupret, Fabrice Lefevre, Laurent Fourage
  • Publication number: 20040002101
    Abstract: Method and kit for using in vitro expression to discover nucleic acids that encode desired functions. Either the existence, presence, identity, properties or function of one or more of the nucleic acids from the sample is unknown to at least the experimenter performing the method or using the kit.
    Type: Application
    Filed: April 11, 2003
    Publication date: January 1, 2004
    Applicant: Proteus S.A.
    Inventors: Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre
  • Publication number: 20030104417
    Abstract: Method of gene shuffling using oriented ligation, whereby at least two fragments are adjacently hybridized on an assembly template. Invention is particularly aimed at generating novel polynucleotides that differ in some advantageous respect compared to a reference sequence. Invention further includes sequences created by the method, hosts and vectors containing same, and proteins translated therefrom.
    Type: Application
    Filed: April 25, 2002
    Publication date: June 5, 2003
    Applicant: Proteus S.A.
    Inventors: Daniel Dupret, Jean Michel Masson, Fabrice Lefevre
  • Patent number: 6514703
    Abstract: The present invention is directed to a process for the separation and characterization of the functions potentially present in a biological sample containing nucleic acids, characterized in that it comprises the steps of preparation of nucleic acid fragments starting from said sample, association of each one of said fragments with a vector molecule, isolation of each fragment associated with a vector molecule or with a part of each construction composed of a fragment associated with a vector molecule, in vitro treatment of each fragment associated with a vector molecule or of a part of each construction composed of a fragment associated with a vector molecule to obtain transcripts, and testing of the function of the transcripts or of the proteins encoded thereby after translation of said transcripts.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: February 4, 2003
    Assignee: Proteus S.A.
    Inventors: Daniel Dupret, Jean-Michel Masson, Fabrice Lefevre